February 4, 2026

What To Expect When You’re Negotiating a Term Sheet

Subscribe to Our Newsletter

Newsletter


William C. Marra

|

February 4, 2026

When a claimant and a litigation funder agree that a case merits further consideration, the next step in the funding process is typically the issuance of a term sheet.


Term sheets are familiar instruments in finance, M&A, and investment transactions. In litigation finance, they serve a similar function: outlining the key economic and structural terms of a proposed funding arrangement before the parties incur the time and expense of full diligence and documentation.


Most litigation finance term sheets are short—often just a few pages—and non-binding. They are designed to confirm alignment on the principal terms of a transaction, not to finalize it.



What a Term Sheet Is — and Is Not


A term sheet is not a funding agreement. It does not obligate either party to proceed with a transaction. Instead, it provides a framework for diligence and negotiation by identifying the essential elements of a proposed deal.


At a minimum, a litigation finance term sheet typically addresses:


  • The parties to the proposed transaction
  • The specific claims or cases to be funded
  • The amount of capital to be committed
  • How that capital will be used
  • How proceeds will be distributed if the case resolves successfully


While many provisions are later refined, the term sheet sets expectations that shape the remainder of the process.



Scope of Funding


One of the first items addressed is the scope of the funded matter.


The term sheet will identify which claims or cases are included—particularly important where a claimant or law firm submits a portfolio for consideration. Not every case under review necessarily meets a funder’s underwriting criteria, and the term sheet should make clear which matters are included and which are not.



Amount and Use of Capital


The term sheet will specify the total amount of capital the funder proposes to commit and how that capital is allocated.


In most funded matters, capital is earmarked for:

  • Legal fees, often funded in part, with the law firm responsible for the balance (e.g., 50% of its fees) and subject to a cap. The law firm is typically responsible for all fees incurred above the cap.


  • Case expenses, such as experts, discovery vendors, and court costs, often funded at a higher percentage but also subject to a cap. The claimant is usually responsible for all case expenses incurred above the cap.


  • Claim monetization / working capital, in appropriate cases. This is non-recourse financing that may be used by the claimant for general corporate purposes, secured by the funded matter.


The term sheet allocates both the amount of fees and costs, and responsibility for costs incurred above agreed caps. These provisions underscore the importance of a realistic litigation budget, as overruns are typically borne by the law firm or claimant rather than the funder.



Returns and Waterfalls


A central feature of any term sheet is the return structure—how proceeds will be distributed if the case resolves successfully.


Most term sheets include a waterfall, a priority-based distribution mechanism commonly used in finance. While structures vary, waterfalls typically provide that:


  • Funders recover their deployed capital before profits are distributed


  • Law firms may recover deferred fees or earn contingent compensation


  • Claimants receive the balance of proceeds, often representing the largest share of the recovery


The precise sequencing and economics depend on the risk profile of the case, the amount of capital deployed, and the parties’ respective contributions. Importantly, waterfalls matter most in downside or mid-range outcomes. In strong recoveries, the parties often reach their target economics well before the waterfall’s final tiers come into play.



Additional Common Provisions


Term sheets may also address:


  • Transaction or underwriting fees payable upon closing


  • Exclusivity periods during diligence


  • Rights of first refusal relating to future matters


  • Circumstances under which either party may withdraw, and whether withdrawal results in a break fee payable by the claimant.


These provisions are typically refined during diligence and documentation but are useful to surface early.



From Term Sheet to Funding Agreement


After a term sheet is executed, funders usually enter an exclusivity period—often 30 to 45 days—during which they conduct comprehensive diligence and negotiate a definitive funding agreement.


That agreement, not the term sheet, governs the parties’ rights and obligations. Understanding the term sheet, however, is essential to navigating what follows.



Closing Thought



A well-drafted term sheet does not merely summarize economics. It reflects a shared understanding of risk, incentives, and strategy at an early—but critical—stage of the litigation.


Approached thoughtfully, the term sheet process can set the foundation for a productive funding relationship aligned with the goals of both counsel and client.

Certum Group Can Help

Get in touch to start discussing options.

Recent Content

By Ross Weiner May 5, 2026
Class action litigators who practice in the BIPA space received clarity in April 2026 following the Seventh Circuit Court of Appeals’ decision in Clay v. Union Pacific Railroad Co. (“Clay”).[1] In a concise 17-page opinion, the court held that the Illinois General Assembly’s 2024 BIPA amendments, which established that BIPA damages should be evaluated on a per-person basis, should be applied retroactively to cases pending at the time of enactment. This decision is a setback for plaintiffs’ counsel who had invested heavily—in time and resources—in BIPA litigation as the next major vehicle for class action recovery. An overview of how we got here is below followed by a summary of the decision. History of BIPA In 2008, Illinois enacted the Biometric Information Privacy Act to respond to the “increasing use of biometric data in commerce.”[2] BIPA was intended to give individuals the right to control their biometric identifiers and information while providing a right of action and meaningful damages against entities that mishandled them. But one question quickly came to the fore: was a new claim accruing each and every time an employer collected the same information from the same employee? As one defendant argued, such a per-scan theory of claim accrual would create “potentially crippling financial liability” for employers who violate BIPA by “repeatedly collecting the same information in the same way.”[3] Recognizing the question’s importance, the Seventh Circuit, in Cothron v. White Castle System, Inc., certified the question of claim accrual to the Supreme Court of Illinois. During briefing, the defendant invoked Section 20—which sets the damages a plaintiff can recover “for each violation”—to dissuade the court from adopting its per-scan reading of Section 15, citing potentially astronomical awards. In a 2023 decision, the Illinois Supreme Court sided with the plaintiffs and held that pursuant to Section 15, claims accrue “with every scan or transmission” of biometric information.[4] The Illinois Supreme Court acknowledged the prospect of “potentially excessive damage awards,” but noted that concern is “best addressed by the legislature.”[5] Accordingly, the court concluded its opinion by “respectfully suggest[ing] that the legislature review these policy concerns and make clear its intent regarding the assessment of damages under the Act.”[6] The Illinois General Assembly Acts Less than a year and a half after Cothron, the Illinois General Assembly heeded the court’s call and passed an amendment that added two clauses to Section 20. The first provided that any entity that collects biometric information “in more than one instance… from the same person using the same method of collection in violation of subsection (b) of Section 15 has committed a single violation…for which the aggrieved person is entitled to, at most, one recovery under this Section.[7] The second added the same operative language for violations of Section 15(d).[8] Going forward, it was now clear that only “one recovery” was available per person (regardless of how many scans there were), transforming potentially excessive damages into more modest ones. But the legislature left one question open: should the amendments apply retroactively to cases already in progress? The Clay Decision According to the Seventh Circuit, Illinois courts have a simple decision tree when it comes to assessing retroactivity. First, did the legislation expressly indicate the temporal reach of the amendment? If yes, case closed. If not, then the court must assess whether the amendment in question constituted a substantive or procedural change to the law. Under Illinois law, a substantive amendment “prescribes the rights, duties, and obligations of persons to one another as to their conduct or property and … determines when a cause of action for damages or other relief has arisen.”[9] Conversely, a procedural amendment involves the “rules that prescribe the steps for having a right or duty judicially enforced, as opposed to the law that defines the specific rights or duties themselves.”[10] While the Clay court acknowledged that the distinction between the two can, in many different contexts, “be unclear,”[11] the court had no trouble deciding the case at bar for one simple reason: the “amendment to BIPA Section 20 is a remedial change,”[12] and “the Supreme Court of Illinois treats remedial changes as procedural, not substantive.”[13] Two features of the amendments were critical: First, the legislature located the amendments in Section 20, which governs liquidated damages, rather than Section 15, which sets the substantive standards for liability under the Act. Second, the amendments’ plain language “focuses on remedies,”[14] indicating that an “aggrieved person is entitled to, at most, one recovery under this Section.”[15] The court’s analysis was straightforward. For those BIPA litigants involved in currently pending cases, the litigation terrain just got bumpier for plaintiffs and more favorable for defendants. Plaintiffs’ settlement leverage in these cases has been significantly reduced. Nevertheless, with enough putative class members, BIPA cases could still be worth bringing, even if they are no longer as valuable. We will continue to monitor the ramifications of this decision. Notes: [1] No. 25-2185 (7th Cir. Apr. 1, 2026). [2] Id. at 3. [3] Id. [4] Cothron v. White Castle System, Inc., 216 N.E.3d at 921 (Ill. 2023). [5] Id. at 929. [6] Id. [7] 740 ILCS 14/20(b). [8] Id. at 14/20(c). [9] Perry v. Dept. of Fin. & Prof. Regulation, 106 N.E.3d 1016, 1034 (Ill. 2018). [10] Id. [11] Clay at 8. [12] Id. at 9. [13] Id. at 8. [14] Id. at 10. [15] 740 ILCS 14/20(b), (c) (emphasis added).
By Certum Team April 23, 2026
The International Legal Finance Association (ILFA) submitted a letter this week to the Civil Procedural Rules Committee of the Supreme Court of Pennsylvania, highlighting the benefits of litigation funding and the risks associated with the mandatory disclosure of funding. The Supreme Court of Pennsylvania is considering a rule that would require mandatory disclosure at the outset of litigation of third-party funding agreements where the funder has a right to control or influence the litigation. ILFA’s letter emphasized that the vast majority of courts—including Pennsylvania courts—have declined to require discovery of funding agreements, in part because such disclosure would breach work product and attorney-client privilege protections. The ILFA letter also emphasized that the leading studies of disclosure by state courts—performed in Delaware and Texas—both concluded that third-party funding does not present significant ethical issues warranting automatic disclosure of funding at the outset of litigation. The full text of ILFA’s letter is available here .
By Certum Team April 14, 2026
Lawdragon, a leading independent legal research company, has recognized six Certum Group professionals to its 2026 Lawdragon 100 Global Leaders in Litigation Finance. The Guide recognizes the leading practitioners in the field of legal risk assessment and litigation funding. The six members of the Certum team recognized were Patrick Dempsey , Joel Fineberg , Dean Gresham , William Marra , Tyler Perry , and Kirstine Rogers .  Certum was recognized for a breadth of offerings, including not only litigation finance but also the range of Certum’s insurance offerings including litigation buyout and judgment preservation insurance. Lawdragon also profiled Marra as part of its 2026 rankings, highlighting his ability to “assess legal claims as assets and create pathways forward to pay lawyers to win strong cases.” The full rankings list is available here.